The global portal hypertension management market is expected to be valued at US$ 3.05 billion in 2023, and will likely exhibit a compound annual growth rate (CAGR) of 5% from 2023 to 2033, concludes a recently published report by Future Market Insights. The generic pharmaceutical segment currently leads the market, with the scope of diagnosis …
Category Archives: Healthcare Trends
Retinal Vein Occlusion Treatment Market to reach US$ 2.3 billion by 2023-end, expected to grow at a 5.9% CAGR until 2033: FMI Report
The global market for retinal vein occlusion treatment is likely to register a CAGR of 5.9% from 2023 to 2033. According to Future Market Insights, a valuation of US$ 2.3 billion is expected for the industry by the end of 2023. Retinal vein occlusion is among the most pervasive retinal vascular ailments in older individuals, …
Articulating Paper Forceps Market to Propel with US$ 2.3 Billion Revenue by 2032 due to Increasing Prevalence of Dental Procedures Globally | FMI
The global Articulating Paper Forceps Market is expected to witness a positive growth outlook by registering a CAGR of 5.2% over the forecast period from 2022 to 2032. The global market is estimated to reach US$ 1.4 Billion in 2022 and is anticipated to reach US$ 2.3 Billion by 2032. According to the Future Market …
Cancer-Focused Genetic Testing Services Market is expected to generate USD 18.55 billion by 2032 | FMI
The global Cancer-Focused Genetic Testing Services Market is estimated to create lucrative growth opportunities by exhibiting a total CAGR of 10% during the projection period from 2022 to 2032. The global market is expected to secure US$ 7.15 Billion by 2022 and is projected to procure USD 18.55 Billion by 2032. According to the historical …
Ulcerated Ncerobiosis Lipoidica Management Market to reach US$ 7.9 billion by 2033, expected to grow at a CAGR of over 6% | FMI Study
The global ulcerated necrobiosis lipoidica management market is anticipated to attain an impressive valuation of US$ 4.4 billion in 2023 and is projected to reach US$ 7.9 billion by 2033, trailing a CAGR of 6.03 % during the forecast period. Increasing advanced diagnostic technique for diagnosis of necrobiosis lipoidica like magnetic resonance imaging is expected …
Global Urinary Retention Therapeutics Market to touch US$ 7.5 billion in 2033, Stress Incontinence to comprise over 38% of all Treatments: FMI Study
The global urinary retention therapeutics market size is anticipated to attain an impressive valuation of USD 3.44 billion in 2023 and is projected to reach US$ 7.5 billion by 2033, expected to register a CAGR of 8.11% until 2033, as per a recently published Future Market Insights study. The market is anticipated to be fuelled …
Unstable Angina Therapeutics Market to expand at a CAGR of 5%, reaching a market value of US$ 6.6 billion by 2033 | FMI
According to a recently published Future Market Insights report, the global unstable angina therapeutics market is forecast to expand at a CAGR of 5% until 2033, reaching US$ 6.6 billion. Based on a Cleveland Clinic study, approximately 200,000 Americans suffer from unstable angina every year. Unstable angina is more prevalent among older people, men, and those …
Fuchs Endothelial Corneal Dystrophy (FECD) Market is expected to reach a valuation of US$ 370 Billion by 2033 | Says FMI Analyst
According to a recent FMI study, the global Fuchs Endothelial Corneal Dystrophy (FECD) market will grow at a 7.5% CAGR from 2023 to 2033. The market is expected to be valued at US$ 370 billion by the end of the assessment period. The primary variables impacting the market growth rate include an increase in the …
Difficile Infections (Clostridium Difficile Associated Disease) Market is expected to be worth US$ 1,448.75 million by 2033 | FMI Study
The worldwide Difficile Infections (Clostridium Difficile Associated Disease) Market is predicted to reach a valuation of US$ 809 Million in 2023, with a CAGR of 6% predicted from 2023 to 2033. Clostridium difficile infection (CDI) is a disease caused by toxic compounds produced by the spore-forming bacteria “Clostridium difficile” found in the intestinal tract. It …
HER2 Positive Gastric Cancer Market is expected to be valued at US$ 1779.8 million by 2033 | FMI
The global HER2 Positive Gastric Cancer Market is currently valued at US$ 1261.8 million in 2023, with a CAGR of 3.5% expected. Because of technological advancements in healthcare, the market is expected to reach US$ 1779.8 million by 2033. “Increased disease burden and pipeline candidate approval are likely to drive the growth of the HER2 …